Investigating how ceramide affects neurodegenerative diseases like Alzheimer's
Function of ceramide in extracellular vesicle-mediated neurodegenerative disease
This study is looking at how a substance called ceramide affects tiny particles that can harm brain cells in Alzheimer's disease, and it's for anyone interested in finding new ways to protect the brain from damage caused by this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10498396 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of ceramide in the formation of extracellular vesicles that contribute to neurodegeneration in Alzheimer's disease. The team will explore how these vesicles, produced by astrocytes in response to amyloid beta, can lead to neuronal damage. By studying the enzymes involved in ceramide metabolism, the researchers aim to identify potential therapeutic targets that could prevent neurotoxicity. The approach includes both in vitro and in vivo experiments to assess the impact of inhibiting ceramide generation on Alzheimer's pathology.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with neurodegenerative diseases other than Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that slow down or prevent cognitive decline in Alzheimer's patients.
How similar studies have performed: Previous studies have shown promising results in targeting ceramide metabolism for neurodegenerative diseases, indicating potential for success in this approach.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Bieberich, Erhard — University of Kentucky
- Study coordinator: Bieberich, Erhard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.